The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Cellular Therapy (CT) Market Research Report 2025
Synopsis
Cellular therapy (CT) is a therapy in which viable cells are injected, grafted or implanted into a patient in order to effectuate a medicinal effect, for example, by transplanting T-cells capable of fighting cancer cells via cell-mediated immunity in the course of immunotherapy, or grafting stem cells to regenerate diseased tissues.
The global Cellular Therapy (CT) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Cellular Therapy (CT), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cellular Therapy (CT).
Report Scope
The Cellular Therapy (CT) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cellular Therapy (CT) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cellular Therapy (CT) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Gilead Sciences
Novartis
Osiris
Vericel Corporation
Vcanbio
Fujifilm Cellular Dynamics
JCR Pharmaceuticals
Beike Biotechnology
Golden Meditech
Guanhao Biotech
Segment by Type
Stem Cell
Non-Stem Cell
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cellular Therapy (CT) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Cellular therapy (CT) is a therapy in which viable cells are injected, grafted or implanted into a patient in order to effectuate a medicinal effect, for example, by transplanting T-cells capable of fighting cancer cells via cell-mediated immunity in the course of immunotherapy, or grafting stem cells to regenerate diseased tissues.
The global Cellular Therapy (CT) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Cellular Therapy (CT), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cellular Therapy (CT).
Report Scope
The Cellular Therapy (CT) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cellular Therapy (CT) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cellular Therapy (CT) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Gilead Sciences
Novartis
Osiris
Vericel Corporation
Vcanbio
Fujifilm Cellular Dynamics
JCR Pharmaceuticals
Beike Biotechnology
Golden Meditech
Guanhao Biotech
Segment by Type
Stem Cell
Non-Stem Cell
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cellular Therapy (CT) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cellular Therapy (CT) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Stem Cell
1.2.3 Non-Stem Cell
1.3 Market by Application
1.3.1 Global Cellular Therapy (CT) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cellular Therapy (CT) Market Perspective (2019-2030)
2.2 Cellular Therapy (CT) Growth Trends by Region
2.2.1 Global Cellular Therapy (CT) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cellular Therapy (CT) Historic Market Size by Region (2019-2024)
2.2.3 Cellular Therapy (CT) Forecasted Market Size by Region (2025-2030)
2.3 Cellular Therapy (CT) Market Dynamics
2.3.1 Cellular Therapy (CT) Industry Trends
2.3.2 Cellular Therapy (CT) Market Drivers
2.3.3 Cellular Therapy (CT) Market Challenges
2.3.4 Cellular Therapy (CT) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cellular Therapy (CT) Players by Revenue
3.1.1 Global Top Cellular Therapy (CT) Players by Revenue (2019-2024)
3.1.2 Global Cellular Therapy (CT) Revenue Market Share by Players (2019-2024)
3.2 Global Cellular Therapy (CT) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cellular Therapy (CT) Revenue
3.4 Global Cellular Therapy (CT) Market Concentration Ratio
3.4.1 Global Cellular Therapy (CT) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cellular Therapy (CT) Revenue in 2023
3.5 Cellular Therapy (CT) Key Players Head office and Area Served
3.6 Key Players Cellular Therapy (CT) Product Solution and Service
3.7 Date of Enter into Cellular Therapy (CT) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cellular Therapy (CT) Breakdown Data by Type
4.1 Global Cellular Therapy (CT) Historic Market Size by Type (2019-2024)
4.2 Global Cellular Therapy (CT) Forecasted Market Size by Type (2025-2030)
5 Cellular Therapy (CT) Breakdown Data by Application
5.1 Global Cellular Therapy (CT) Historic Market Size by Application (2019-2024)
5.2 Global Cellular Therapy (CT) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cellular Therapy (CT) Market Size (2019-2030)
6.2 North America Cellular Therapy (CT) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cellular Therapy (CT) Market Size by Country (2019-2024)
6.4 North America Cellular Therapy (CT) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cellular Therapy (CT) Market Size (2019-2030)
7.2 Europe Cellular Therapy (CT) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cellular Therapy (CT) Market Size by Country (2019-2024)
7.4 Europe Cellular Therapy (CT) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cellular Therapy (CT) Market Size (2019-2030)
8.2 Asia-Pacific Cellular Therapy (CT) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cellular Therapy (CT) Market Size by Region (2019-2024)
8.4 Asia-Pacific Cellular Therapy (CT) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cellular Therapy (CT) Market Size (2019-2030)
9.2 Latin America Cellular Therapy (CT) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cellular Therapy (CT) Market Size by Country (2019-2024)
9.4 Latin America Cellular Therapy (CT) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cellular Therapy (CT) Market Size (2019-2030)
10.2 Middle East & Africa Cellular Therapy (CT) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cellular Therapy (CT) Market Size by Country (2019-2024)
10.4 Middle East & Africa Cellular Therapy (CT) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Gilead Sciences
11.1.1 Gilead Sciences Company Detail
11.1.2 Gilead Sciences Business Overview
11.1.3 Gilead Sciences Cellular Therapy (CT) Introduction
11.1.4 Gilead Sciences Revenue in Cellular Therapy (CT) Business (2019-2024)
11.1.5 Gilead Sciences Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Cellular Therapy (CT) Introduction
11.2.4 Novartis Revenue in Cellular Therapy (CT) Business (2019-2024)
11.2.5 Novartis Recent Development
11.3 Osiris
11.3.1 Osiris Company Detail
11.3.2 Osiris Business Overview
11.3.3 Osiris Cellular Therapy (CT) Introduction
11.3.4 Osiris Revenue in Cellular Therapy (CT) Business (2019-2024)
11.3.5 Osiris Recent Development
11.4 Vericel Corporation
11.4.1 Vericel Corporation Company Detail
11.4.2 Vericel Corporation Business Overview
11.4.3 Vericel Corporation Cellular Therapy (CT) Introduction
11.4.4 Vericel Corporation Revenue in Cellular Therapy (CT) Business (2019-2024)
11.4.5 Vericel Corporation Recent Development
11.5 Vcanbio
11.5.1 Vcanbio Company Detail
11.5.2 Vcanbio Business Overview
11.5.3 Vcanbio Cellular Therapy (CT) Introduction
11.5.4 Vcanbio Revenue in Cellular Therapy (CT) Business (2019-2024)
11.5.5 Vcanbio Recent Development
11.6 Fujifilm Cellular Dynamics
11.6.1 Fujifilm Cellular Dynamics Company Detail
11.6.2 Fujifilm Cellular Dynamics Business Overview
11.6.3 Fujifilm Cellular Dynamics Cellular Therapy (CT) Introduction
11.6.4 Fujifilm Cellular Dynamics Revenue in Cellular Therapy (CT) Business (2019-2024)
11.6.5 Fujifilm Cellular Dynamics Recent Development
11.7 JCR Pharmaceuticals
11.7.1 JCR Pharmaceuticals Company Detail
11.7.2 JCR Pharmaceuticals Business Overview
11.7.3 JCR Pharmaceuticals Cellular Therapy (CT) Introduction
11.7.4 JCR Pharmaceuticals Revenue in Cellular Therapy (CT) Business (2019-2024)
11.7.5 JCR Pharmaceuticals Recent Development
11.8 Beike Biotechnology
11.8.1 Beike Biotechnology Company Detail
11.8.2 Beike Biotechnology Business Overview
11.8.3 Beike Biotechnology Cellular Therapy (CT) Introduction
11.8.4 Beike Biotechnology Revenue in Cellular Therapy (CT) Business (2019-2024)
11.8.5 Beike Biotechnology Recent Development
11.9 Golden Meditech
11.9.1 Golden Meditech Company Detail
11.9.2 Golden Meditech Business Overview
11.9.3 Golden Meditech Cellular Therapy (CT) Introduction
11.9.4 Golden Meditech Revenue in Cellular Therapy (CT) Business (2019-2024)
11.9.5 Golden Meditech Recent Development
11.10 Guanhao Biotech
11.10.1 Guanhao Biotech Company Detail
11.10.2 Guanhao Biotech Business Overview
11.10.3 Guanhao Biotech Cellular Therapy (CT) Introduction
11.10.4 Guanhao Biotech Revenue in Cellular Therapy (CT) Business (2019-2024)
11.10.5 Guanhao Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
